Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Grant/Award of 37,653 OBX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Obsidian Therapeutics, Inc. (OBX) | Grant/Award | 37,653 | n/a |
| May 11, 2026 | REVVITY, INC. (RVTY) | Grant/Award | 1,015 | n/a |
| May 1, 2025 | REVVITY, INC. (RVTY) | Grant/Award | 1,074 | n/a |
| May 2, 2024 | REVVITY, INC. (RVTY) | Grant/Award | 977 | n/a |
| Jan 4, 2024 | SYNLOGIC, INC. (SYBX) | Grant/Award | 24,923 | n/a |
| Jun 26, 2023 | SYNLOGIC, INC. (SYBX) | Grant/Award | 30,000 | n/a |
| May 17, 2023 | REVVITY, INC. (RVTY) | Grant/Award | 783 | n/a |
| Jan 4, 2023 | SYNLOGIC, INC. (SYBX) | Grant/Award | 156,130 | n/a |
| Jun 13, 2022 | SYNLOGIC, INC. (SYBX) | Grant/Award | 27,000 | n/a |
| May 13, 2022 | Larimar Therapeutics, Inc. (LRMR) | Grant/Award | 8,300 | n/a |